Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of voglibose added to alogliptin in Japanese patients with diabetes mellitus

Trial Profile

Efficacy of voglibose added to alogliptin in Japanese patients with diabetes mellitus

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Sep 2015

At a glance

  • Drugs Voglibose (Primary) ; Alogliptin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Oct 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 22 Apr 2013 Planned number of patients changed from 60 to 180 as reported by University Hospital Medical Information Network - Japan.
    • 22 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top